|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
EP0699754B2
(en)
|
1994-08-12 |
2009-08-12 |
The University of Utah Research Foundation |
Method for diagnosing a predisposition for breast and ovarian cancer
|
|
DE69521002T3
(de)
|
1994-08-12 |
2010-02-25 |
The University Of Utah Research Foundation, Salt Lake City |
Mutationen des mit 17q verbundenen Ovarial- und Brustkrebs Empfindlichkeitsgens
|
|
JP4334141B2
(ja)
|
1998-04-20 |
2009-09-30 |
グリカート バイオテクノロジー アクチェンゲゼルシャフト |
抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作
|
|
EP2275540B1
(en)
|
1999-04-09 |
2016-03-23 |
Kyowa Hakko Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
|
AR024464A1
(es)
|
1999-06-25 |
2002-10-02 |
Genentech Inc |
Anticuerpos anti-erbb2 humanizados.
|
|
CN103333860B
(zh)
|
2000-10-06 |
2015-07-08 |
协和发酵麒麟株式会社 |
产生抗体组合物的细胞
|
|
CA2647632C
(en)
|
2006-03-27 |
2017-06-27 |
University Of Maryland Biotechnology Institute |
Glycoprotein synthesis and remodeling by enzymatic transglycosylation
|
|
JP6282232B2
(ja)
|
2012-02-10 |
2018-02-21 |
ユニバーシティー オブ メリーランド，ボルティモア |
抗体及びそのＦｃフラグメントの酵素化学的糖鎖改変
|
|
US10195288B2
(en)
|
2012-10-11 |
2019-02-05 |
Daiichi Sankyo Company, Limited |
Antibody-drug conjugate
|
|
SG10201902571VA
(en)
|
2013-12-25 |
2019-04-29 |
Daiichi Sankyo Co Ltd |
Anti-trop2 antibody-drug conjugate
|
|
SG11201603960XA
(en)
|
2014-01-31 |
2016-07-28 |
Daiichi Sankyo Co Ltd |
Anti-her2 antibody-drug conjugate
|
|
TWI871999B
(zh)
|
2014-04-10 |
2025-02-01 |
日商第一三共股份有限公司 |
抗her3抗體-藥物結合物
|
|
CA2990572C
(en)
|
2015-06-29 |
2022-07-26 |
Daiichi Sankyo Company, Limited |
Method for selectively manufacturing antibody-drug conjugate
|
|
TWI926682B
(zh)
|
2017-05-15 |
2026-05-21 |
日商第一三共股份有限公司 |
抗體－藥物結合物之製造方法
|
|
EP3677589B1
(en)
|
2017-08-31 |
2025-11-26 |
Daiichi Sankyo Company, Limited |
Improved method for producing antibody-drug conjugate
|
|
CA3082579A1
(en)
|
2017-11-15 |
2019-05-23 |
Mirati Therapeutics, Inc. |
Kras g12c inhibitors
|
|
TW202012415A
(zh)
|
2018-05-08 |
2020-04-01 |
瑞典商阿斯特捷利康公司 |
化學化合物
|
|
ES3010507T3
(en)
|
2019-03-05 |
2025-04-03 |
Astrazeneca Ab |
Fused tricyclic compounds useful as anticancer agents
|
|
CR20220258A
(es)
|
2019-12-11 |
2022-07-03 |
Lilly Co Eli |
Inhibidores de kras g12c
|
|
CN116034106B
(zh)
|
2020-06-02 |
2025-11-04 |
勃林格殷格翰国际有限公司 |
用于治疗癌症的环状2-氨基-3-氰基噻吩及衍生物
|